journal of thrombosis and thrombolysis سال:2020 - دوره:49

Fa | Ar | En


journal of thrombosis and thrombolysis
سال:2020 - دوره:49 - شماره:2

a case report of severe bleeding due to lupus anticoagulant hypoprothrombinemia syndrome - صفحه:334-336 antithrombotic therapy for chronic coronary syndrome and atrial fibrillation: less might be more - صفحه:321-324 change in matrix metalloproteinase 2, 3, and 9 levels at the time of and after acute atherothrombotic myocardial infarction - صفحه:235-244 congenital fibrinogen disorders with repeated thrombosis - صفحه:312-315 determination of the cut-off prothrombin time to estimate plasma rivaroxaban overdose status - صفحه:245-250 direct oral anticoagulants: a review on the current role and scope of reversal agents - صفحه:271-286 does telehealth improve anticoagulation management in patient service centers (psc)? a pilot project - صفحه:316-320 drug interactions and pharmacogenetic factors contribute to variation in apixaban concentration in atrial fibrillation patients in routine care - صفحه:294-303 evaluation of intravenous direct thrombin inhibitor monitoring tests: correlation with plasma concentrations and clinical outcomes in hospitalized patients - صفحه:259-267 extended prophylaxis of venous thromboembolism with betrixaban in acutely ill medical patients with and without cancer: insights from the apex trial - صفحه:214-219 factors associated with women’s adherence to postpartum thromboprophylaxis - صفحه:304-311 global thromboelastometry in patients receiving direct oral anticoagulants: the ro-doa study - صفحه:251-258 high incidence of under-treated atrial fibrillation: perspectives from an asian stroke endovascular thrombectomy registry - صفحه:268-270 incidence of residual perfusion defects by lung scintigraphy in patients treated with rivaroxaban compared with warfarin for acute pulmonary embolism - صفحه:220-227 induction of tissue factor expression by anti-β2-glycoprotein i is mediated by tumor necrosis factor α - صفحه:228-234 initiation of a fixed- dose four- factor prothrombin complex concentrate protocol - صفحه:332-333 intravenous unfractionated heparin dosing in obese patients using anti-xa levels - صفحه:206-213 low persistence to rivaroxaban or warfarin among patients with new venous thromboembolism at a safety net academic medical center - صفحه:287-293 rationale and design of “can very low dose rivaroxaban (vldr) in addition to dual antiplatelet therapy improve thrombotic status in acute coronary syndrome (validate-r)” study - صفحه:192-198 resolution of acute lower extremity deep vein thrombosis with rivaroxaban compared to warfarin - صفحه:199-205 the dawn of aspirin free strategy after short term dual antiplatelet for percutaneous coronary intervention: meta-analysis of randomized controlled trials - صفحه:184-191 the role of anticoagulation in pylephlebitis: a retrospective examination of characteristics and outcomes - صفحه:325-331 tissue-level inflammation and ventricular remodeling in hypertrophic cardiomyopathy - صفحه:177-183